US Cardiac Arrhythmia Case Could Stoke International CBD Safety Worries
Executive Summary
A patient admitted to a US emergency department after experiencing dizziness and fainting without warning is found to have been using a cocktail of herbal dietary supplements, including CBD and CBG. The case could fuel international worries about CBD's safety, for example in the EU, where novel food applications were recently put on hold by EFSA because of safety data gaps.
You may also be interested in...
Hemp Roundtable Says Safety Study Data Should Convince Congress On Lawful CBD Use
Study of 1,061 subjects showed oral CBD has robust safety profile, addressing FDA’s safety concerns and providing evidence to convince agency to take action on CBD regulation, say trade groups.
UK CBD Industry Vexed As FSA Publishes Searchable Public List – A Year Late
The UK Food Standards Agency has published its much anticipated searchable, online CBD public list. But after a long wait, the list's publication has triggered a wave of anxiety and criticism from CBD firms and experts.
GSK Signals CBD Interest With Agreement For Potential Australian Launch
GSK will evaluate the launch potential in Australia of a non-prescription CBD product currently being studied as a short-term treatment for sleep disturbances. The firm also has first refusal to negotiate the rights to market the product – developed by Cann Group – in other countries around the world.